Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology

Clinical and Experimental Pharmacology and Physiology

Volumn 30, Issue 11, 2003, Pages 849-854

  Bengtsson, Sara H M ^a   Gulluyan, Lerna M ^a   Dusting, Gregory J ^a   Drummond, Grant R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Atherosclerosis; gp91phox; NADPH oxidase; Nox1; Nox4; Vascular pathophysiology; Vascular physiology

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN GP 91; HOX PROTEIN; HYDROGEN PEROXIDE; ISOENZYME; ISOPROTEIN; MESSENGER RNA; NOX1 PROTEIN; NOX4 PROTEIN; PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; UNCLASSIFIED DRUG;

ARTERY INJURY; ARTERY WALL; ATHEROGENESIS; BLOOD VESSEL WALL; CARDIOVASCULAR SYSTEM; CELL CYCLE; CONFERENCE PAPER; DEFENSE MECHANISM; ELECTRON TRANSPORT; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME SUBUNIT; FIBROBLAST; GENE EXPRESSION; HYPERCHOLESTEROLEMIA; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTE; PROTEIN EXPRESSION; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; ISOENZYMES; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; VASCULAR DISEASES;

EID: 0344736917     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2003.03929.x     Document Type: Conference Paper

References (53)

1. + channels. Stroke 1997; 28: 2290-5.
2. Lacza Z, Puskar M, Kis B, Perciaccante JV, Miller AW, Busija DW. Hydrogen peroxide acts as an EDHF in the piglet pial vasculature in response to bradykinin. Am. J. Physiol Heart Circ. Physiol. 2002; 283: H406-11.
3. Matoba T, Shimokawa H, Kubota H et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem. Biophys. Res. Commun. 2002; 290: 909-13.
4. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J. Biol. Chem. 1998; 273: 15 022-9.
5. Ushio-Fukai M, Alexander RW, Akers M et al. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J. Biol. Chem. 1999; 274: 22 699-704.
6. Fei J, Viedt C, Soto U, Elsing C, Jahn L, Kreuzer J. Endothelin-1 and smooth muscle cells: Induction of jun amino-terminal kinase through an oxygen radical-sensitive mechanism. Arterioscler. Thromb. Vasc. Biol. 2000; 20: 1244-9.
7. Frank GD, Eguchi S, Yamakawa T, Tanaka S, Inagami T, Motley ED. Involvement of reactive oxygen species in the activation of tyrosine kinase and extracellular signal-regulated kinase by angiotensin II. Endocrinology 2000; 141: 3120-6.
8. Kyaw M, Yoshizumi M, Tsuchiya K, Kirima K, Tamaki T. Anti-oxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells. Hypertens. Res. 2001; 24: 251-61.
9. Kyaw M, Yoshizumi M, Tsuchiya K et al. Antioxidants inhibit endothelin-1 (1-31)-induced proliferation of vascular smooth muscle cells via the inhibition of mitogen-activated protein (MAP) kinase and activator protein-1 (AP-1). Biochem. Pharmacol. 2002; 64: 1521-31.
10. Puri PL, Avantaggiati ML, Burgio VL et al. Reactive oxygen intermediates (ROIs) are involved in the intracellular transduction of angiotensin II signal in C2C12 cells. Ann. N.Y. Acad. Sci. 1995; 752: 394-405.
11. Rao GN, Katki KA, Madamanchi NR, Wu Y, Birrer MJ. JunB forms the majority of the AP-1 complex and is a target for redox regulation by receptor tyrosine kinase and G protein-coupled receptor agonists in smooth muscle cells. J. Biol. Chem. 1999; 274: 6003-10.
12. Gorlach A, Diebold I, Schini-Kerth VB et al. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22 (phox)-containing NADPH oxidase. Circ. Res. 2001; 89: 47-54.
13. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler. Thromb. Vasc. Biol. 2000; 20: 2175-83.
14. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ. Res. 2000; 87: 840-4.
15. Fukai T, Folz RJ, Landmesser U, Harrison DG. Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc. Res. 2002; 55: 239-49.
16. Satoh T, Tokunaga O. Intracellular oxidative modification of low density lipoprotein by endothelial cells. Virchows Arch. 2002; 440: 410-17.
17. Fu S, Davies MJ, Stocker R, Dean RT. Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem. J. 1998; 333: 519-25.
18. Pennathur S, Wagner JD, Leeuwenburgh C, Litwak KN, Heinecke JW. A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease. J. Clin. Invest. 2001; 107: 853-60.
19. Yu JW, Yoon SS, Yang R. Iron chlorin e6 scavenges hydroxyl radical and protects human endothelial cells against hydrogen peroxide toxicity. Biol. Pharm. Bull. 2001; 24: 1053-9.
20. Babior BM. NADPH oxidase: An update. Blood 1999; 93: 1464-76.
21. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase. Role in cardiovascular biology and disease. Circ. Res. 2000; 86: 494-501.
22. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ. Res. 2000; 87: 26-32.
23. Frey RS, Rahman A, Kefer JC, Minshall RD, Malik AB. PKCzeta regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells. Circ. Res. 2002; 90: 1012-19.
24. Rey FE, Li XC, Carretero OA, Garvin JL, Pagano PJ. Perivascular superoxide anion contributes to impairment of endothelium-dependent relaxation: Role of gp91 (phox). Circulation 2002; 106: 2497-502.
25. Touyz RM, Chen X, Tabet F et al. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: Regulation by angiotensin II. Circ. Res. 2002; 90: 1205-13.
26. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. p22phox is a critical component of the superoxide-generating NADH/ NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J. Biol. Chem. 1996; 271: 23 317-21.
27. Sorescu D, Weiss D, Lassegue B et al. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 2002; 105: 1429-35.
28. Souza HP, Laurindo FR, Ziegelstein RC, Berlowitz CO, Zweier JL. Vascular NAD(P)H oxidase is distinct from the phagocytic enzyme and modulates vascular reactivity control. Am. J. Physiol. Heart Circ. Physiol. 2001; 280: H658-67.
29. Barry-Lane PA, Patterson C, van der Merwe M et al. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J. Clin. Invest. 2001; 108: 1513-22.
30. Lassegue B, Sorescu D, Szocs K et al. Novel gp91 (phox) homologues in vascular smooth muscle cells: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 2001; 88: 888-94.
31. Suh YA, Arnold RS, Lassegue B et al. Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999; 401: 79-82.
32. Lambeth JD, Cheng G, Arnold RS, Edens WA. Novel homologs of gp91phox. Trends Biochem. Sci. 2000; 25: 459-61.
33. Geiszt M, Kopp JB, Varnai P, Leto TL. Identification of renox, an NAD(P) H oxidase in kidney. Proc. Natl Acad. Sci. USA 2000; 97: 8010-14.
34. Shiose A, Kuroda J, Tsuruya K et al. A novel superoxide-producing NAD(P) H oxidase in kidney. J. Biol. Chem. 2001; 276: 1417-23.
35. Paravicini TM, Gulluyan LM, Dusting GJ, Drummond GR. Increased NADPH oxidase activity, gp91phox expression, and endothelium-dependent vasorelaxation during neointima formation in rabbits. Circ. Res. 2002; 91: 54-61.
36. Warnholtz A, Nickenig G, Schulz E et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: Evidence for involvement of the renin-angiotensin system. Circulation 1999; 99: 2027-33.
37. Patterson C, Ruef J, Madamanchi NR et al. Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47 (phox) may participate in forming this oxidase in vitro and in vivo. J. Biol. Chem. 1999; 274: 19 814-22.
38. Shi Y, Niculescu R, Wang D, Patel S, Davenpeck KL, Zalewski A. Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury. Arterioscler. Thromb. Vasc. Biol. 2001; 21: 739-45.
39. West N, Guzik T, Black E, Channon K. Enhanced superoxide production in experimental venous bypass graft intimai hyperplasia. Role of NAD(P)H oxidase. Arterioscler. Thromb. Vasc. Biol. 2001; 21: 189-94.
40. Berry C, Hamilton CA, Brosnan MJ et al. Investigation into the sources of superoxide in human blood vessels: Angiotensin II increases superoxide production in human internal mammary arteries. Circulation 2000; 101: 2206-12.
41. Zalba G, Beaumont FJ, San Jose G et al. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 2000; 35: 1055-61.
42. Beswick RA, Dorrance AM, Leite R, Webb RC. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 2001; 38: 1107-11.
43. Guzik TJ, West NE, Black E et al. UltraRapid communications: Vascular superoxide production by NAD(P)H oxidase. Association with endothelial dysfunction and clinical risk factors. Circ. Res. 2000; 86: 1008.
44. Brandes RP, Miller FJ, Beer S et al. The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. Free Radic. Biol. Med. 2002; 32: 1116-22.
45. Li JM, Mullen AM, Yun S et al. Essential role of the NADPH oxidase subunit p47 (phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha. Circ. Res. 2002; 90: 143-50.
46. Landmesser U, Cai H, Dikalov S et al. Role of p47 (phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 2002; 40: 511-15.
47. Li JM, Shah AM. Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit. J. Biol. Chem. 2003; 278: 12 094-100.
48. Laursen JB, Somers M, Kurz S et al. Endothelial regulation of vasomotion in apoE-deficient mice: Implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 2001; 103: 1282-8.
49. -) production or endothelial dysfunction. Circulation 2001; 104: 11-71 (Abstract).
50. Kalinina N, Agrotis A, Tararak E et al. Cytochrome b558-dependent NAD(P) H oxidase-phox units in smooth muscle and macrophages of atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 2002; 22: 2037-43.
51. Mollnau H, Wendt M, Szocs K et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ. Res. 2002; 90: E58-65.
52. Szocs K, Lassegue B, Sorescu D et al. Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler. Thromb. Vasc. Biol. 2002; 22: 21-7.
53. Kirk EA, Dinauer MC, Rosen H, Chait A, Heinecke JW, LeBoeuf RC. Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 2000; 20: 1529-35.